Metagenomi Therapeutics (MGX) Return on Assets (2024 - 2026)

Metagenomi Therapeutics (MGX) has 3 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets slipped to 0.0% in Q1 2026 per MGX's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q2 2024 and troughed at 0.0% in Q1 2026.
• A 3-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
• On a YoY basis, Return on Assets climbed as much as 0 bps in 2025 and fell as far as 0 bps in 2025.
• A 3-year view of Return on Assets shows it stood at 0.0% in 2024, then plunged by 64 bps to 0.0% in 2025, then slipped by 10 bps to 0.0% in 2026.
• Business Quant data shows MGX's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.